Advertisement

The Respiratory Nurse in Pulmonary Rehabilitation

  • Vanessa M. McDonald
  • Mary Roberts
  • Kerry Inder
Chapter

Abstract

The respiratory nurse has an important role in the assessment and delivery of pulmonary rehabilitation. The training, expert knowledge, and skills of respiratory nurses allow them undertake multidimensional assessment and to work with patients to tailor specific therapeutic interventions and to coordinate the delivery of person centered care.

Respiratory nurses in particular have an important role in the provision of patient education and self-management, symptom management and monitoring, and primary and secondary prevention strategies to improve health and prevent deterioration.

The role of the respiratory nurse in symptom, comorbidity, exacerbation, and medication management is outlined in this chapter. Further highlighted is the role of the respiratory nurse in adherence assessment and management, inhaler technique assessment and correction and smoking cessation.

References

  1. 1.
    Spruit MA, Singh SJ, Garvey C, Zuwallack R, Nici L, Rochester C, et al. An official american thoracic society/european respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64.CrossRefPubMedGoogle Scholar
  2. 2.
    Watson J. Caring science as sacred science. Philadelphia, PA: FA Davis Company; 2005.Google Scholar
  3. 3.
    Hunter DJ, Fairfield G. Disease management. Br Med J. 1997;315(7099):50–3.CrossRefGoogle Scholar
  4. 4.
    Hunter DJ. Disease management: has it a future? It has a compelling logic, but needs to be tested in practice. Br Med J. 2000;320(7234):530.CrossRefGoogle Scholar
  5. 5.
    Case Management Society of America. What is a case manager? 2013. http://www.cmsa.org/Home/CMSA/WhatisaCaseManager/tabid/224/Default.aspx.
  6. 6.
    Bourbeau J, Lavoie KL, Sedeno M. Comprehensive self-management strategies. Semin Respir Crit Care Med. 2015;36(4):630–8.CrossRefPubMedGoogle Scholar
  7. 7.
    McDonald VM, Higgins I, Wood LG, Gibson PG. Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense? Thorax. 2013;68(7):691–4.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    McDonald VM, Higgins I, Simpson JL, Gibson PG. The importance of clinical management problems in older people with COPD and asthma; do patients and physicians agree? Prim Care Respir J. 2011;20(4):389–95.CrossRefPubMedGoogle Scholar
  9. 9.
    Gibson PG, McDonald VM, Marks GB. Asthma in the Older Adult. Lancet. 2010;374(9743):803–13.CrossRefGoogle Scholar
  10. 10.
    McDonald VM, Higgins I, Gibson PG. Managing older patients with coexistent asthma and COPD: diagnostic and therapeutic challenges. Drugs Aging. 2013;30(1):1–17.CrossRefPubMedGoogle Scholar
  11. 11.
    From the Global Strategy for the Diagnosis, Management and Prevention of COPD. Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2016 [Internet]. http://goldcopd.org/. Accessed 11 Oct 2016.
  12. 12.
    Vanfleteren LEGW, Spruit MA, Groenen M, Gaffron S, Van Empel VPM, Bruijnzeel PLB, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–35.CrossRefPubMedGoogle Scholar
  13. 13.
    Barr RG, Celli BR, Mannino DM, Petty T, Rennard SI, Sciurba FC, et al. Comorbidities, patient knowledge, and disease management in a national sample of patients with COPD. Am J Med. 2009;122(4):348–55.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: Impact, measurement and mechanisms. Respirology. 2015;20(8):1160–71.CrossRefPubMedGoogle Scholar
  15. 15.
    George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369–76.CrossRefPubMedGoogle Scholar
  16. 16.
    Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310.CrossRefGoogle Scholar
  17. 17.
    Willson MN, Greer CL, Weeks DL. Medication regimen complexity and hospital readmission for an adverse drug event. Ann Pharmacother. 2014;48(1):26–32.CrossRefPubMedGoogle Scholar
  18. 18.
    McDonald VM, Simpson JL, Higgins I, Gibson PG. Multidimensional assessment of older people with asthma & copd: clinical management and health status. Age Ageing. 2011;40(1):42–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Lareau SC, Hodder R. Teaching inhaler use in chronic obstructive pulmonary disease patients. J Am Acad Nurse Pract. 2012;24(2):113–20.CrossRefPubMedGoogle Scholar
  20. 20.
    Basheti IA, Armour CL, Bosnic-Anticevich SZ, Reddel HK. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns. 2008;72(1):26–33.CrossRefPubMedGoogle Scholar
  21. 21.
    Bosnic-Anticevich SZ, Sinha H, So S, Reddel HK. Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma. 2010;47(3):251–6.CrossRefPubMedGoogle Scholar
  22. 22.
    McDonald VM, Gibson PG. Inhalation device polypharmacy in asthma. Med J Aust. 2005;182(5):250–1.PubMedGoogle Scholar
  23. 23.
    McDonald VM, Gibson PG. Asthma education. In: Bernstein JA, Levy ML, editors. Clinical asthma: theory and practice, vol. 1. Bosa Roca, USA: CRC Press; 2014.Google Scholar
  24. 24.
    Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema: report of the Medical Research Council Working Party. Lancet. 1981;317:681–6.CrossRefGoogle Scholar
  25. 25.
    Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2001;5(4):513–8.CrossRefGoogle Scholar
  26. 26.
    McDonald CF, Whyte K, Jenkins S, Serginson J, Frith P. Clinical practice guideline on adult domiciliary oxygen therapy: executive summary from the thoracic society of Australia and New Zealand. Respirology. 2016;21(1):76–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Pavord ID, Jones PW, Burgel PR, Rabe KF. Exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11(Spec Iss):21–30.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Hillas G, Perlikos F, Tzanakis N. Acute exacerbation of COPD: is it the “stroke of the lungs”? Int J Chron Obstruct Pulmon Dis. 2016;11:1579–86.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Kessler R, Stahl E, Vogelmeier C, Haughney J, Trudeau E, Lofdahl CG, et al. Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest. 2006;130(1):133–42.CrossRefPubMedGoogle Scholar
  30. 30.
    Langsetmo L, Platt RW, Ernst P, Bourbeau J. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008;177(4):396–401.CrossRefPubMedGoogle Scholar
  31. 31.
    Hurst JR, Donaldson GC, Quint JK, Goldring JJ, Baghai-Ravary R, Wedzicha JA. Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(5):369–74.CrossRefPubMedGoogle Scholar
  32. 32.
    Howcroft M, Walters EH, Wood-Baker R, Walters JA. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12:CD005074.PubMedGoogle Scholar
  33. 33.
    Gibson PG, Powell H. Written action plans for asthma: an evidence-based review of the key components. Thorax. 2004;59:94–9.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Neugaard BI, Priest JL, Burch SP, Cantrell CR, Foulis PR. Quality of care for veterans with chronic diseases: performance on quality indicators, medication use and adherence, and health care utilization. Popul Health Manag. 2011;14(2):99–106.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Bryant J, McDonald VM, Boyes A, Sanson-Fisher R, Paul C, Melville J. Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2013;14:109.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Negewo NA, McDonald VM, Gibson PG. Comorbidity in COPD. Respir Investig. 2015;53(6):249–58.CrossRefPubMedGoogle Scholar
  37. 37.
    Singh D, Miravitlles M, Vogelmeier C. Chronic obstructive pulmonary disease individualized therapy: tailored approach to symptom management. Adv Ther. 2017;34(2):281–99.CrossRefPubMedGoogle Scholar
  38. 38.
    Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, et al. Symptom variability in patients with severe COPD: a pan-European cross-sectional study. Eur Respir J. 2011;37(2):264–72.CrossRefPubMedGoogle Scholar
  39. 39.
    Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, et al. Impact of COPD in North America and Europe in 2000: subjects’ perspective of Confronting COPD International Survey. Eur Respir J. 2002;20(4):799–805.CrossRefPubMedGoogle Scholar
  40. 40.
    Johnson M, Carlo B, Currow D, Maddocks M, McDonald V, Mahadeva R, et al. Management of chronic breathlessness: non-pharmacological and pharmacological interventions. ERS Monogr. 2016;73:153–71.Google Scholar
  41. 41.
    Franssen FM, Rochester CL. Comorbidities in patients with COPD and pulmonary rehabilitation: do they matter? Eur Respir Rev. 2014;23(131):131–41.CrossRefPubMedGoogle Scholar
  42. 42.
    Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SSNHLBI. WHO Global initiative for chronic obstructive lung disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.CrossRefPubMedGoogle Scholar
  43. 43.
    National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax. 2004;59(1 Suppl):1S–232S.Google Scholar
  44. 44.
    Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J. 2004;23(3):464–76.CrossRefPubMedGoogle Scholar
  45. 45.
    Hill K, Vogiatzis I, Burtin C. The importance of components of pulmonary rehabilitation, other than exercise training, in COPD. Eur Respir Rev. 2013;22(129):405–13.CrossRefPubMedGoogle Scholar
  46. 46.
    van Eerd EA, van der Meer RM, van Schayck OC, Kotz D. Smoking cessation for people with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;8:CD010744.Google Scholar
  47. 47.
    Rice VH, Hartmann-Boyce J, Stead LF. Nursing interventions for smoking cessation. Cochrane Database Syst Rev. 2013;8:CD001188.Google Scholar
  48. 48.
    Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2008;1:CD000146. doi:10.1002/14651858.CD000146.pub3.CrossRefGoogle Scholar
  49. 49.
    Vozoris NT, Stanbrook MB. Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respir Med. 2011;105(3):477–84.CrossRefPubMedGoogle Scholar
  50. 50.
    Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219–29.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Welfare AIoHa. Chronic respiratory diseases in Australia: their prevalence, consequences and prevention. Canberra; 2005.Google Scholar
  52. 52.
    D’Amato G, Vitale C, D'Amato M, Cecchi L, Liccardi G, Molino A, et al. Thunderstorm-related asthma: what happens and why. Clin Exp Allergy. 2016;46(3):390–6.CrossRefPubMedGoogle Scholar
  53. 53.
    Cafarella PA, Effing TW, Usmani ZA, Frith PA. Treatments for anxiety and depression in patients with chronic obstructive pulmonary disease: a literature review. Respirology. 2012;17(4):627–38.CrossRefPubMedGoogle Scholar
  54. 54.
    Jennings JH, Digiovine B, Obeid D, Frank C. The association between depressive symptoms and acute exacerbations of COPD. Lung. 2009;187(2):128–35.CrossRefPubMedGoogle Scholar
  55. 55.
    Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007;167(1):60–7.CrossRefPubMedGoogle Scholar
  56. 56.
    Laurin C, Moullec G, Bacon SL, Lavoie KL. Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012;185(9):918–23.CrossRefPubMedGoogle Scholar
  57. 57.
    Abrams TE, Vaughan-Sarrazin M, Van der Weg MW. Acute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortality. Psychosomatics. 2011;52(5):441–9.CrossRefPubMedGoogle Scholar
  58. 58.
    Keating A, Lee A, Holland AE. What prevents people with chronic obstructive pulmonary disease from attending pulmonary rehabilitation? A systematic review. Chron Respir Dis. 2011;8(2):89–99.CrossRefPubMedGoogle Scholar
  59. 59.
    Zhang MW, Ho RC, Cheung MW, Fu E, Mak A. Prevalence of depressive symptoms in patients with chronic obstructive pulmonary disease: a systematic review, meta-analysis and meta-regression. Gen Hosp Psychiatry. 2011;33(3):217–23.CrossRefPubMedGoogle Scholar
  60. 60.
    Yohannes AM, Baldwin RC, Connolly MJ. Prevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry. 2003;18(5):412–6.CrossRefPubMedGoogle Scholar
  61. 61.
    Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA, et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics. 2000;41(6):465–71.CrossRefPubMedGoogle Scholar
  62. 62.
    Kunik ME, Roundy K, Veazey C, Souchek J, Richardson P, Wray NP, et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest. 2005;127(4):1205–11.PubMedGoogle Scholar
  63. 63.
    Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67(6):361–70.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Lamers F, Jonkers CC, Bosma H, Chavannes NH, Knottnerus JA, van Eijk JT. Improving quality of life in depressed COPD patients: effectiveness of a minimal psychological intervention. COPD. 2010;7(5):315–22.CrossRefPubMedGoogle Scholar
  65. 65.
    Detering KM, Sutton EA, CF M. Recognising advanced disease, advance care planning and recognition of dying for people with COPD. ERS Monogr. 2016;73:204–20.Google Scholar
  66. 66.
    Jones I, Kirby A, Ormiston P, Loomba Y, Chan KK, Rout J, et al. The needs of patients dying of chronic obstructive pulmonary disease in the community. Fam Pract. 2004;21(3):310–3.CrossRefPubMedGoogle Scholar
  67. 67.
    Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55(12):1000–6.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    McDonald VM, HigginsI, Gibson PG. Gaining Insight into Older Australians’ health care experiences with managing COPD and Asthma. J Asthma. 2013;50(5):497–504.CrossRefPubMedGoogle Scholar
  69. 69.
    Haras MS. Planning for a good death: a neglected but essential part of ESRD care. Nephrol Nurs J. 2008;35(5):451–8.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Vanessa M. McDonald
    • 1
    • 2
    • 3
  • Mary Roberts
    • 4
    • 5
    • 6
  • Kerry Inder
    • 1
    • 2
  1. 1.School of Nursing and MidwiferyThe University of NewcastleNew LambtonAustralia
  2. 2.Centre of Excellence for Severe AsthmaThe University of NewcastleNew LambtonAustralia
  3. 3.Priority Research Centre for Healthy LungsThe University of NewcastleNew LambtonAustralia
  4. 4.Department of Respiratory and Sleep MedicineWestmead HospitalWestmeadAustralia
  5. 5.Ludwig Engel Centre of Respiratory ResearchWestmeadAustralia
  6. 6.Westmead Institute for Medical ResearchWestmeadAustralia

Personalised recommendations